Product Information

CARBAMAZEPINE ER 300 MG CAP is a generic product labeled by Apotex Corp., priced at $1.0113 per EA under NDC 60505280707. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Nov 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE ER 300 MG CAP

Carbamazepine
$1.0113per EA

Strength

300 mg/1

Manufacturer

Apotex Corp.

NDC

60505280707

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078986

FDA Approved

11/25/2011

TE Code

AB

On Market Since

3/23/2012

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE ER 300 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0113 per EA
All-time high$1.4793 (Dec 11, 2019)
All-time low$0.6362 (Oct 17, 2018)
52-week high$1.1200
52-week low$1.0113
Median price$1.1006
Average price$1.1103
Largest weekly change+73.2% (May 1, 2019)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-5.3%

1M

-5.3%

3M

-9.7%

6M

-7.4%

1Y

-0.1%

3Y

-2.4%

5Y

-17.6%

All

-24.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE ER 300 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 300 MG CAP, manufactured by Apotex Corp., is $1.0113 per EA (NDC 60505280707), effective Aug 19, 2026.

How has the price of CARBAMAZEPINE ER 300 MG CAP changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE ER 300 MG CAP has declined 24.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 300 MG CAP?

Since Nov 28, 2013, the NADAC for CARBAMAZEPINE ER 300 MG CAP has ranged from a low of $0.6362 (Oct 17, 2018) to a high of $1.4793 (Dec 11, 2019), with a median of $1.1006 per EA.

Are there cheaper alternatives to CARBAMAZEPINE ER 300 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBAMAZEPINE ER 300 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBAMAZEPINE ER 300 MG CAP?

CARBAMAZEPINE ER 300 MG CAP (NDC 60505280707) is labeled by Apotex Corp., and CMS classifies it as a generic product.